SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001178913-12-001916
Filing Date
2012-07-12
Accepted
2012-07-12 11:17:46
Documents
11
Period of Report
2012-05-31
Filing Date Changed
2012-07-12

Document Format Files

Seq Description Document Type Size
1 10-Q zk1211676.htm 10-Q 680595
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 16002
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 15984
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 7072
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 6975
  Complete submission text file 0001178913-12-001916.txt   2162759

Data Files

Seq Description Document Type Size
6 INSTANCE DOCUMENT ormp-20120531.xml EX-101.INS 189761
7 TAXONOMY EXTENSION SCHEMA ormp-20120531.xsd EX-101.SCH 13790
8 TAXONOMY EXTENSION CALCULATION LINKBASE ormp-20120531_cal.xml EX-101.CAL 37601
9 TAXONOMY EXTENSION DEFINITION LINKBASE ormp-20120531_def.xml EX-101.DEF 19394
10 TAXONOMY EXTENSION LABEL LINKBASE ormp-20120531_lab.xml EX-101.LAB 230055
11 TAXONOMY EXTENSION PRESENTATION LINKBASE ormp-20120531_pre.xml EX-101.PRE 91453
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-50298 | Film No.: 12958874
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1